Virtual reality headsets could replace sedatives for C-Section anxiety

NCT ID NCT07343843

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether wearing a virtual reality headset with calming scenes can reduce anxiety and stress during a cesarean section as well as a sedative drug called dexmedetomidine. Fifty-two women having planned C-sections will be randomly assigned to receive either the VR headset or the drug through an IV. Researchers will measure anxiety levels, heart rate, blood pressure, and how the baby is doing after birth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dexmedetomidine (sedative drug) and virtual reality (immersive audiovisual content)
What this could lead to
If successful, this could offer a non-drug option (VR) to reduce anxiety during C-sections, avoiding potential side effects of sedatives.
What could go wrong
This is a small, early-stage study (52 participants) comparing two interventions, so results may not apply broadly. The VR approach may not work for everyone, and the drug has known risks like low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Benha University

    RECRUITING

    Banhā, Benha, 13518, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.